Skip to main content
HY
NYSE Technology

Hyster-Yale Seeks Shareholder Approval for Amended Director Equity Plan, Increasing Available Shares

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
7
Price
$30.615
Mkt Cap
$548.011M
52W Low
$26.405
52W High
$46.154
Market data snapshot near publication time

summarizeSummary

Hyster-Yale filed its definitive proxy statement, proposing to increase shares for its non-employee director equity plan and detailing executive compensation in light of 2025 losses, alongside routine governance matters.


check_boxKey Events

  • Director Equity Plan Amendment Proposed

    Shareholders will vote on amending the Non-Employee Directors' Equity Compensation Plan, which would increase the number of Class A Common shares available for issuance by 100,000. This represents a moderate potential dilution for existing shareholders.

  • Executive Compensation Reflects Poor 2025 Performance

    The proxy details executive compensation, showing lower payouts for 2025 due to the company's significant net loss and operating profit decline, indicating alignment with pay-for-performance principles.

  • Annual Shareholder Meeting Scheduled

    The annual meeting will be held on May 12, 2026, where shareholders will vote on the election of fifteen directors, an advisory vote on executive compensation, the director equity plan, and the appointment of Ernst & Young LLP as auditor.

  • Strong Insider Voting Control

    The Rankin family and affiliated entities hold a combined beneficial ownership representing 73.66% of the total voting power, indicating significant insider control over corporate decisions.


auto_awesomeAnalysis

This definitive proxy statement outlines proposals for the upcoming annual meeting, notably seeking shareholder approval to amend the Non-Employee Directors' Equity Compensation Plan. The amendment would increase the number of Class A Common shares available for issuance by 100,000, representing a moderate potential dilution for director compensation. This comes as the company reported a significant net loss and revenue decline for FY2025, which also impacted executive compensation payouts, demonstrating a pay-for-performance alignment. The filing details the company's robust corporate governance structure, including a majority independent board and committees, despite qualifying as a controlled company. Investors should note the substantial voting power held by the Rankin family, which ensures strong insider control over corporate decisions.

At the time of this filing, HY was trading at $30.62 on NYSE in the Technology sector, with a market capitalization of approximately $548M. The 52-week trading range was $26.41 to $46.15. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed HY - Latest Insights

HY
Mar 24, 2026, 11:04 AM EDT
Filing Type: DEF 14A
Importance Score:
7
HY
Mar 04, 2026, 4:34 PM EST
Filing Type: 8-K
Importance Score:
7
HY
Mar 03, 2026, 4:45 PM EST
Filing Type: 8-K
Importance Score:
8
HY
Mar 03, 2026, 4:45 PM EST
Filing Type: 8-K
Importance Score:
8
HY
Mar 03, 2026, 4:43 PM EST
Source: Dow Jones Newswires
Importance Score:
8
HY
Mar 03, 2026, 4:40 PM EST
Filing Type: 10-K
Importance Score:
8